What Researchers Did
Researchers reviewed the long-term visual and structural outcomes, including new blood vessel growth, in four patients who received hyperbaric oxygen therapy (HBOT) shortly after experiencing a central retinal artery occlusion (CRAO).
What They Found
Two patients with non-insulin dependent diabetes developed early eye complications (neovascularization) within one month of treatment, with their final vision being only light perception over a year later. The other two patients, one with diabetes and one without, did not develop these complications and saw their vision improve to 20/400 and 20/250, respectively.
What This Means for Canadian Patients
Canadian patients with central retinal artery occlusion who receive HBOT, particularly those with diabetes, may require more frequent and earlier monitoring for eye complications like neovascularization. This proactive monitoring could help in the timely management of potential long-term vision issues.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This study was limited by its small number of participants, a case series of only four patients, which restricts the generalizability of the findings.